Improving the hit-to-lead process: data-driven assessment of drug-like and lead-like screening hits
- 1 February 2006
- journal article
- review article
- Published by Elsevier in Drug Discovery Today
- Vol. 11 (3-4) , 175-180
- https://doi.org/10.1016/s1359-6446(05)03700-1
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- High-throughput drug discovery: What can we expect from HTS?Drug Discovery Today, 2005
- Fragment-based lead discoveryNature Reviews Drug Discovery, 2004
- Ligand efficiency: a useful metric for lead selectionDrug Discovery Today, 2004
- Strategic trends in the drug industryDrug Discovery Today, 2003
- Nonleadlikeness and leadlikeness in biochemical screeningDrug Discovery Today, 2003
- Chapter 35. Pharmaceutical productivity — the imperative for new paradigmsPublished by Elsevier ,2003
- Drugs, leads, and drug-likeness: an analysis of some recently launched drugsBioorganic & Medicinal Chemistry Letters, 2002
- Is There a Difference between Leads and Drugs? A Historical PerspectiveJournal of Chemical Information and Computer Sciences, 2001
- The Design of Leadlike Combinatorial LibrariesAngewandte Chemie International Edition in English, 1999
- Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settingsAdvanced Drug Delivery Reviews, 1997